Related Experiment Video
Updated: May 15, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Protecting the heart: biological targets and clinical strategies
Alberto R De Caterina1, Florim Cuculi, Adrian P Banning
1Oxford University Hospitals, Headley Way, Oxford OX3 9DU, United Kingdom.
Insights
Restoring blood flow to the heart can paradoxically cause further damage, known as ischemia-reperfusion (IR) injury. This review explores clinical assessments and strategies to protect the heart from this reperfusion injury.
Area of Science:
- Cardiovascular Pathophysiology
- Myocardial Ischemia-Reperfusion Injury
Background:
- Ischemic cardiomyopathy involves complex myocardial damage.
- Restoring blood flow (reperfusion) can paradoxically worsen myocardial injury.
Purpose of the Study:
- To highlight the clinical relevance of ischemia-reperfusion (IR) injury.
- To review clinical assessment methods for IR injury.
- To summarize promising pharmacological and non-pharmacological protective strategies.
Main Methods:
- Review of existing literature on IR injury.
- Focus on molecular events during myocardial reperfusion.
- Analysis of clinical translation potential for protective strategies.
Main Results:
- Identified three key components of IR injury: cardiomyocyte, vascular, and inflammatory damage.
- Emphasized the growing interest in IR injury protection techniques.
- Highlighted the need for strategies to mitigate reperfusion-induced damage.
Conclusions:
- IR injury significantly complicates ischemic cardiomyopathy treatment.
- Clinical assessment and protective strategies are crucial for improving outcomes.
- Further research into pharmacological and non-pharmacological interventions holds promise for clinical practice.
Abstract:
The pathophysiology of myocardial damage in the setting of ischemic cardiomyopathy is complicated by the fact that the process of restoring blood flow to the ischemic cardiomyocytes can itself induce injury to the myocardium. This phenomenon, termed reperfusion injury, reduces the benefits of vessel recanalization and contributes to the damage initiated by occlusion. The interest on techniques aiming at protecting the heart from ischemia-reperfusion (IR) injury has constantly grown over the last two decades. Three main actors of IR injury can be identified: 1) cardiomyocite-related damage, 2) vascular-related injury and 3) inflammatory-related injury. Ideally targeting the series of molecular events that take place during myocardial reperfusion, this area of research focuses on the different strategies that may help to render the heart more resistant to the ischemic insult. The aim of this article is to highlight the clinical relevance of IR injury, how IR-injury can be assessed clinically as well as to review the current strategies, both pharmacological and non pharmacological, that show promise for translation to clinical practice.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Cardiovascular Drugs: Classification based on Therapeutic Indications
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
